From Sal Monela at The Moderate Voice:
By now, most people have heard about the 600% price increase in a medication called an Epi-Pen. The Epi-Pen is a device carrying a drug used by people who experience severe, life threatening allergic reactions.
Needless to say, a number of people, including politicians, have been critical of the manufacturer, Mylan, and it chief executive, Heather Bresch for imposing such an astronomical cost increase on a medication on which the patent has expired. But don’t worry Heather; Kevin Williamson writing in the National Review has heroically ridden to your defense.